REGISTRATION RIGHTS AGREEMENT by and among Haleon plc, Pfizer Inc., GSK plc, GSK (No.1) Scottish Limited Partnership, GSK (No.2) Scottish Limited Partnership, and GSK (No.3) Scottish Limited Partnership Dated as of 1 June, 2022Registration Rights Agreement • June 1st, 2022 • Haleon PLC • Perfumes, cosmetics & other toilet preparations • New York
Contract Type FiledJune 1st, 2022 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT, dated as of 1 June, 2022 (the “Agreement”), is made and entered into by and among (i) Haleon plc, a public limited company incorporated in England and Wales with number 13691224 and whose registered office is at 980 Great West Road, Brentford, Middlesex TW8 9GS (the “Company”), (ii) Pfizer Inc., a Delaware corporation whose registered office is at 235 East 42nd Street, New York, New York 10017 (“Pfizer” and, together with its Affiliates or successors, and permitted assigns from time to time that will hold Registrable Securities of the Company, the “Pfizer Shareholder Group”), (iii) GSK plc, a public limited company incorporated in England and Wales with number 03888792 and whose registered office is at 980 Great West Road, Brentford, Middlesex, TW8 9GS (“GSK”), (iv) GSK (No.1) Scottish Limited Partnership, a limited partnership registered in Scotland with registration number SL035527 and whose principal place of business is at 50 Lothian Road, Festiv
REGISTRATION RIGHTS AGREEMENT by and among Haleon plc, Pfizer Inc., GSK plc, GSK (No.1) Scottish Limited Partnership, GSK (No.2) Scottish Limited Partnership, and GSK (No.3) Scottish Limited Partnership Dated as of [•], 2022Registration Rights Agreement • May 24th, 2022 • Haleon PLC • Perfumes, cosmetics & other toilet preparations • New York
Contract Type FiledMay 24th, 2022 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT, dated as of [•], 2022 (the “Agreement”), is made and entered into by and among (i) Haleon plc, a public limited company incorporated in England and Wales with number 13691224 and whose registered office is at [•] (the “Company”), (ii) Pfizer Inc., a Delaware corporation whose registered office is at 235 East 42nd Street, New York, New York 10017 (“Pfizer” and, together with its Affiliates or successors, and permitted assigns from time to time that will hold Registrable Securities of the Company, the “Pfizer Shareholder Group”), (iii) GSK plc, a public limited company incorporated in England and Wales with number 03888792 and whose registered office is at 980 Great West Road, Brentford, Middlesex, TW8 9GS (“GSK”), (iv) GSK (No.1) Scottish Limited Partnership, a limited partnership registered in Scotland with registration number SL035527 and whose principal place of business is at 50 Lothian Road, Festival Square, Edinburgh, EH3 9WJ (“SLP 1”), (v) GSK